-
1
-
-
77149169736
-
Early Crohn disease: A proposed definition for use in disease-modification trials
-
Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. Early Crohn disease: a proposed definition for use in disease-modification trials. Gut. 2010;59:141-147.
-
(2010)
Gut
, vol.59
, pp. 141-147
-
-
Peyrin-Biroulet, L.1
Loftus Jr., E.V.2
Colombel, J.F.3
Sandborn, W.J.4
-
2
-
-
77954423661
-
Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: An analysis of PRECiSE 2 randomized maintenance trial data
-
PRECiSE 2 Study Investigators
-
Schreiber S, Colombel JF, Bloomfield R, et al; PRECiSE 2 Study Investigators. Increased response and remission rates in short-duration Crohn's disease with subcutaneous certolizumab pegol: an analysis of PRECiSE 2 randomized maintenance trial data. Am J Gastroenterol. 2010;105:1574-1582.
-
(2010)
Am J Gastroenterol
, vol.105
, pp. 1574-1582
-
-
Schreiber, S.1
Colombel, J.F.2
Bloomfield, R.3
-
3
-
-
79951696378
-
Development of the Crohn's disease digestive damage score, the Lémann score
-
Nov 28. Epub ahead of print
-
Pariente B, Cosnes J, Danese S, et al. Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis. 2010 Nov 28. Epub ahead of print.
-
(2010)
Inflamm Bowel Dis
-
-
Pariente, B.1
Cosnes, J.2
Danese, S.3
-
4
-
-
74049136834
-
Disability in inflammatory bowel diseases: Developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health
-
Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Disability in inflammatory bowel diseases: developing ICF Core Sets for patients with inflammatory bowel diseases based on the International Classification of Functioning, Disability, and Health. Inflamm Bowel Dis. 2010;16:15-22.
-
(2010)
Inflamm Bowel Dis
, vol.16
, pp. 15-22
-
-
Peyrin-Biroulet, L.1
Cieza, A.2
Sandborn, W.J.3
-
5
-
-
39449085441
-
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: An open randomized trial
-
Belgian Inflammatory Bowel Disease Research Group; North-Holland Gut Club
-
D'Haens G, Baert F, van Assche G, et al; Belgian Inflammatory Bowel Disease Research Group; North-Holland Gut Club. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomized trial. Lancet. 2008;371:660-667.
-
(2008)
Lancet
, vol.371
, pp. 660-667
-
-
D'Haens, G.1
Baert, F.2
Van Assche, G.3
-
6
-
-
77950988234
-
Infliximab, azathioprine, or combination therapy for Crohn's disease
-
SONIC Study Group
-
Colombel JF, Sandborn WJ, Reinisch W, et al; SONIC Study Group. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010;362:1383-1395.
-
(2010)
N Engl J Med
, vol.362
, pp. 1383-1395
-
-
Colombel, J.F.1
Sandborn, W.J.2
Reinisch, W.3
|